Growth Hormone Deficiency clinical trials at UCSF
2 research studies open to eligible people
Growth hormone deficiency is when the body makes too little growth hormone, which affects growth and energy. UCSF is running studies that monitor long term safety of a weekly growth hormone used in care. UCSF is also collecting real world data on how well this treatment works over time.
Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
open to eligible people ages 1-18
The goal of this study is to further characterise the potential long-term safety risks of lonapegsomatropin in patients treated with lonapegsomatropin under real-world conditions in the post-marketing setting.
San Francisco, California and other locations
US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
open to eligible people ages 1-18
The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care
San Francisco, California and other locations
Last updated: